Core B: Human Stem Cell Core
$411,039P30FY2012DKNIH
Children'S Hosp Of Philadelphia, Philadelphia PA
Investigators
Linked publications & trials
Paper 29884903Paper 28053997Paper 26974155Paper 26227841Paper 26172292Paper 26168347Paper 26045259Paper 25992652Paper 25984238Paper 25961454Paper 25852052Paper 25729644Paper 25636339Paper 25621499Paper 25512554Paper 25477496Paper 25468352Paper 25411427Paper 25395423Paper 25319996Paper 25319994Paper 25241935Paper 25127216Paper 24939847Paper 24778156Paper 24652993Paper 24631742Paper 24497530Paper 24446170Paper 24412757Paper 24335497Paper 24268694Paper 23990565Paper 23940280Paper 23744582Paper 23645840Paper 23620576Paper 23446734Paper 23430657Paper 23388674Paper 23142822Paper 23045704Paper 22982896Paper 22855609Paper 22812478Paper 22611153Paper 22427201Paper 21561349
Abstract
Two pre-existing functional Core Facilities will be merged under this proposal and focused on supporting the UPENN/CHOP program in benign hematopoiesis. This combined service will be entitled the Human Stem Cell Core B and will be directed by Dr. Mitchell Weiss. The two SubCores are 1) SubCore B-1, the Hematopoietic Stem Cell (HSC) Facility at UPENN, directed by Martin Carroll, and 2) SubCore B-2, the Human Embryonic Stem (ES) and Induced Pluripotent Stem (iPS) Cell Facility, which is physically present at CHOP, and will be directed by Dr. Deborah French.
View original record on NIH RePORTER →